Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
190 participants
INTERVENTIONAL
2014-07-01
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Foveal Sparing ILM Peeling With ILM Flap Transposition
NCT05897671
Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes
NCT04498624
Clinical Research on the Effect of Different Extents of Internal Limiting Membrane Peeling on Macular Hole Closure and Visual Acuity
NCT03805763
Effects of Different Area of Internal Limiting Membrane Peeling (ILM) Peeling on Anatomical Outcomes in Macular Hole Surgery
NCT02930369
ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study
NCT03646695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Complete Peeling
Patient underwent scheduled vitrectomy for epiretinal membrane or macular hole with complete macular peeling of the internal limiting membrane.
Complete Macular Peeling
A complete peeling of the internal limiting membrane was performed
Foveal Sparing
Patient underwent scheduled vitrectomy for epiretinal membrane or macular hole with partial peeling the internal limiting membrane (foveal sparing).
Macular Peeling with Foveal Sparing
A partial peeling of the internal limiting membrane was performed, sparing the fovea.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Complete Macular Peeling
A complete peeling of the internal limiting membrane was performed
Macular Peeling with Foveal Sparing
A partial peeling of the internal limiting membrane was performed, sparing the fovea.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 60 years
* presence of idiopathic macular pucker or macular hole documented by OCT
Exclusion Criteria
* pathologic myopia (\> 7 diopters)
* age related macular degeneration
* glaucoma and diabetic retinopathy or any other retinal vascular disease
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Università degli Studi di Brescia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francesco Semeraro
Francesco Semeraro; MD, Associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Vitreo003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.